Humira approved for treating psoriatic arthritis joint damage
The Food and Drug Administration has approved Humira for a new use. Humira may now be used to slow joint damage in people with psoriatic arthritis. Humira is already approved to treat other aspects of psoriatic arthritis. It is also approved for the treatment of rheumatoid arthritis and ankylosing spondylitis, an inflammatory disease of the spine.
(Forbes.com) UPDATED 11/14/2006Click here to read the full story

